SGN-CD19B: Clinical Trials

1 trial of SGN-CD19B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow SGN-CD19B: new trials by email Literature Review of SGN-CD19B trials Research Report on SGN-CD19B

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma
SGN-CD19B - Non-Hodgkin Lymphoma, DLBCL
Phase 1TerminatedSeagen Inc.442016-02-012018-08-13

Conditions studied

Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Non-Hodgkin (1)

Sponsors

Seagen Inc. (1)

Countries

United States (1)

Top investigators

Juan Pinelli, PA-C, MMSc (1)

Results publications

PMID 28903943